Display Settings:

Format

Send to:

Choose Destination
    Arch Womens Ment Health. 2007;10(3):125-7. Epub 2007 Apr 16.

    Symptom-onset dosing with citalopram in the treatment of premenstrual dysphoric disorder (PMDD): a case series.

    Source

    Department of Psychiatry, University of Toronto, Toronto, Canada. arun_ravindran@camh.net

    Abstract

    The efficacy and tolerability of symptom-onset dosing with citalopram in the treatment of premenstrual dysphoric disorder (PMDD) was evaluated in an open trial. Eight outpatients, aged 18-45 years and diagnosed with PMDD, were treated with 10-20 mg of citalopram from the start of premenstrual symptoms until the onset of menses. Primary efficacy variables were the premenstrual tension scale (PMTS-O) and the clinical global impression of improvement (CGI). Treatment was associated with significant improvement in PMDD symptoms (p < 0.001).

    PMID:
    17431739
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Springer

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk